These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20959542)

  • 1. Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?
    Lamb HJ
    Radiology; 2010 Nov; 257(2):307-8. PubMed ID: 20959542
    [No Abstract]   [Full Text] [Related]  

  • 2. MR imaging evaluation of cardiovascular risk in metabolic syndrome.
    van der Meer RW; Lamb HJ; Smit JW; de Roos A
    Radiology; 2012 Jul; 264(1):21-37. PubMed ID: 22723560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR of multi-organ involvement in the metabolic syndrome.
    Bizino MB; Sala ML; de Heer P; van der Tol P; Smit JW; Webb AG; de Roos A; Lamb HJ
    Magn Reson Imaging Clin N Am; 2015 Feb; 23(1):41-58. PubMed ID: 25476673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating mixed hyperlipidaemia.
    Viljoen A; Wierzbicki AS
    BMJ; 2011 Aug; 343():d5146. PubMed ID: 21868456
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation and Comparison of Various Anthropometric Measurements of Body Fat Distribution and Sagittal Abdominal Diameter as a Screening Tool for Cardio Metabolic Risk Factors and Ischaemic Heart Disease in Elderly Population.
    Sharda M; Jain P; Gupta A; Nagar D; Soni A
    J Assoc Physicians India; 2015 Jan; 63(1):22-6. PubMed ID: 26591123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
    Lara-Castro C; Luo N; Wallace P; Klein RL; Garvey WT
    Diabetes; 2006 Jan; 55(1):249-59. PubMed ID: 16380500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinaemia.
    Phillips P
    Aust Fam Physician; 2004 Apr; 33(4):241-2. PubMed ID: 15129469
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of MRI and CT for fat imaging in children and youth: what have we learned about obesity, fat distribution and metabolic disease risk?
    Samara A; Ventura EE; Alfadda AA; Goran MI
    Obes Rev; 2012 Aug; 13(8):723-32. PubMed ID: 22520361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases.
    Magni P; Macchi C; Sirtori CR; Corsi Romanelli MM
    Clin Chem Lab Med; 2016 Oct; 54(10):1579-87. PubMed ID: 26863345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemical pathology of insulin resistance and the metabolic syndrome.
    Harris NS; Winter WE
    MLO Med Lab Obs; 2004 Oct; 36(10):20, 22-5. PubMed ID: 15536804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and ectopic fat deposition: what can CT and MR provide?
    Meng K; Lee CH; Saremi F
    Acad Radiol; 2010 Oct; 17(10):1302-12. PubMed ID: 20605492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome.
    Gong W; Ren H; Tong H; Shen X; Luo J; Chen S; Lai J; Chen X; Chen H; Yu W
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():339-45. PubMed ID: 17392130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome.
    Jarrett RJ
    Lancet; 2005 Dec; 366(9501):1922; author reply 1923-4. PubMed ID: 16325690
    [No Abstract]   [Full Text] [Related]  

  • 15. New imaging techniques of fat, muscle and liver within the context of determining insulin sensitivity.
    Stefan N; Machann J; Schick F; Claussen CD; Thamer C; Fritsche A; Häring HU
    Horm Res; 2005; 64 Suppl 3():38-44. PubMed ID: 16439843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified indication of metabolic syndrome to recognize subjects with a moderate risk to develop type 2 diabetes mellitus in a large Italian sample.
    Sacco S; Comelli M; Molina V; Montrasio PL; Giani E; Cavanna F
    Acta Diabetol; 2014 Feb; 51(1):35-41. PubMed ID: 23494826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI measurement of liver fat content predicts the metabolic syndrome.
    Ducluzeau PH; Boursier J; Bertrais S; Dubois S; Gauthier A; Rohmer V; Gagnadoux F; Leftheriotis G; Cales P; Andriantsitohaina R; Roullier V; Aubé C
    Diabetes Metab; 2013 Sep; 39(4):314-21. PubMed ID: 23523139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study.
    Targher G; Bertolini L; Tessari R; Zenari L; Arcaro G
    Diabet Med; 2006 Nov; 23(11):1270-1. PubMed ID: 17054609
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current studies on new parameters of metabolic syndrome].
    Jia WP; Xiang KS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):737-9. PubMed ID: 17260457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.